IHS Chemical Week

Regions :: Western Europe

Aptuit Buys Evotec’s Chemical Development Arm

8:32 AM MDT | October 3, 2007 | Alex Scott

Drug development services group Aptuit (Greenwich, CT) says it has acquired the chemical development business of drug discovery firm Evotec (Hamburg) for $64 million in cash. The acquired business comprises activities in process R&D, custom preparation, analytical development, pilot plant manufacturing, and formulation. The business has about 210 staff based at Oxford and Glasgow, U.K., and generated 2006 sales of €26.8 million ($37.2 million). “This acquisition continues Aptuit’s momentum as we assemble a complete suite of drug development...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa